Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter 2024 Results Conference Call. Currently all participants are in a listen-only mode.
Humacyte Inc. (HUMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Altium Capital Jacob Gottlieb | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Tudor Investment Corp Paul Tudor Jones | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.35 | 2,362 | Officer, Director | 240,832 | 2024-06-04 | Filing | |
| $6.35 | 2,362 | Director | 240,832 | 2024-06-04 | Filing | |
| $7.37 | 2,050 | Officer, Director | 238,470 | 2024-06-03 | Filing | |
| $7.37 | 2,050 | Director | 238,470 | 2024-06-03 | Filing | |
| $6.29 | 3,990 | Director | 3,990 | 2024-05-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.30 | 271,518 | Officer, Director | 4,559,140 | 2024-06-12 | Filing | |
| $7.02 | 76,630 | Officer, Director | 4,830,658 | 2024-06-11 | Filing | |
| $7.09 | 282,000 | Officer, Director | 4,907,288 | 2024-06-11 | Filing | |
| $7.30 | 271,518 | Director | 4,559,140 | 2024-06-12 | Filing | |
| $7.02 | 76,630 | Director | 4,830,658 | 2024-06-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
10 Stocks American Politicians are Buying in 2024
In this article, we will take a detailed look at the 10 Stocks American Politicians are Buying in 2024. For a quick overview of such stocks, read our article 5 Stocks American Politicians are Buying...
Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte 2023 Fourth Quarter Year-End Results Conference Call. Currently, all participants are in a listen-only mode.
11 Little-Known Penny Stocks With Massive Upside Potential
In this article, we will take a detailed look at the 11 Little-Known Penny Stocks With Massive Upside Potential. For a quick overview of such stocks, read our article 5 Little-Known Penny Stocks With...
Humacyte, Inc. (NASDAQ:HUMA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Humacyte Third Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q4 2022 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Fourth Quarter and Year-End 2022 Results Conference Call. Currently, all participants are in a listen-only mode.
4 Best Stocks to Buy According to Billionaire James Dinan
This article discusses the top 4 stock picks of James Dinan’s York Capital Management at the end of June 2022.
Top 10 Stocks To Buy According To Billionaire James Dinan
In this article, we discuss the top 10 stocks to buy according to billionaire James Dinan.
Billionaire Hedge Funds
